1980 related articles for article (PubMed ID: 8228328)
1. Novel and known protein tyrosine kinases and their abnormal expression in human melanoma.
Easty DJ; Ganz SE; Farr CJ; Lai C; Herlyn M; Bennett DC
J Invest Dermatol; 1993 Nov; 101(5):679-84. PubMed ID: 8228328
[TBL] [Abstract][Full Text] [Related]
2. Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis.
Easty DJ; Herlyn M; Bennett DC
Int J Cancer; 1995 Jan; 60(1):129-36. PubMed ID: 7814145
[TBL] [Abstract][Full Text] [Related]
3. A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes.
Lee ST; Strunk KM; Spritz RA
Oncogene; 1993 Dec; 8(12):3403-10. PubMed ID: 8247543
[TBL] [Abstract][Full Text] [Related]
4. Protein tyrosine phosphatase genes downregulated in melanoma.
McArdle L; Rafferty M; Maelandsmo GM; Bergin O; Farr CJ; Dervan PA; O'Loughlin S; Herlyn M; Easty DJ
J Invest Dermatol; 2001 Nov; 117(5):1255-60. PubMed ID: 11710941
[TBL] [Abstract][Full Text] [Related]
5. Isolation of a cDNA encoding a tyrosine kinase expressed in murine skin.
Kawachi Y; Nakauchi H; Otsuka F
Exp Dermatol; 1997 Jun; 6(3):140-6. PubMed ID: 9226137
[TBL] [Abstract][Full Text] [Related]
6. Protein kinases in normal and transformed melanocytes.
Quong RY; Bickford ST; Ing YL; Terman B; Herlyn M; Lassam NJ
Melanoma Res; 1994 Oct; 4(5):313-9. PubMed ID: 7858416
[TBL] [Abstract][Full Text] [Related]
7. c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas.
Funasaka Y; Boulton T; Cobb M; Yarden Y; Fan B; Lyman SD; Williams DE; Anderson DM; Zakut R; Mishima Y
Mol Biol Cell; 1992 Feb; 3(2):197-209. PubMed ID: 1372524
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine kinases in malignant melanoma.
Easty DJ; Bennett DC
Melanoma Res; 2000 Oct; 10(5):401-11. PubMed ID: 11095400
[TBL] [Abstract][Full Text] [Related]
9. Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?
Gilhooly EM; Morse-Gaudio M; Bianchi L; Reinhart L; Rose DP; Connolly JM; Reed JA; Albino AP
Melanoma Res; 2001 Aug; 11(4):355-69. PubMed ID: 11479424
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma.
Easty DJ; Mitchell PJ; Patel K; Flørenes VA; Spritz RA; Bennett DC
Int J Cancer; 1997 Jun; 71(6):1061-5. PubMed ID: 9185712
[TBL] [Abstract][Full Text] [Related]
12. Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities.
Gutman M; Singh RK; Radinsky R; Bar-Eli M
Anticancer Res; 1994; 14(5A):1759-65. PubMed ID: 7847808
[TBL] [Abstract][Full Text] [Related]
13. PTK1, a novel protein kinase required for proliferation of human melanocytes.
Ezoe K; Lee ST; Strunk KM; Spritz RA
Oncogene; 1994 Mar; 9(3):935-8. PubMed ID: 8108137
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of protein kinase C and cAMP-dependent protein kinase in normal human melanocytes and malignant melanomas.
Becker D; Beebe SJ; Herlyn M
Oncogene; 1990 Aug; 5(8):1133-9. PubMed ID: 2392322
[TBL] [Abstract][Full Text] [Related]
15. Growth factors and tyrosine protein kinases in normal and malignant melanocytes.
Halaban R
Cancer Metastasis Rev; 1991 Jun; 10(2):129-40. PubMed ID: 1873853
[TBL] [Abstract][Full Text] [Related]
16. Elevated procaspase levels in human melanoma.
Fink D; Schlagbauer-Wadl H; Selzer E; Lucas T; Wolff K; Pehamberger H; Eichler HG; Jansen B
Melanoma Res; 2001 Aug; 11(4):385-93. PubMed ID: 11479427
[TBL] [Abstract][Full Text] [Related]
17. Putative tyrosine kinases expressed in K-562 human leukemia cells.
Partanen J; Mäkelä TP; Alitalo R; Lehväslaiho H; Alitalo K
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8913-7. PubMed ID: 2247464
[TBL] [Abstract][Full Text] [Related]
18. Receptor tyrosine kinases and their activation in melanoma.
Easty DJ; Gray SG; O'Byrne KJ; O'Donnell D; Bennett DC
Pigment Cell Melanoma Res; 2011 Jun; 24(3):446-61. PubMed ID: 21320293
[TBL] [Abstract][Full Text] [Related]
19. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.
Easty DJ; Guthrie BA; Maung K; Farr CJ; Lindberg RA; Toso RJ; Herlyn M; Bennett DC
Cancer Res; 1995 Jun; 55(12):2528-32. PubMed ID: 7780963
[TBL] [Abstract][Full Text] [Related]
20. Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins.
Teutschbein J; Haydn JM; Samans B; Krause M; Eilers M; Schartl M; Meierjohann S
BMC Cancer; 2010 Jul; 10():386. PubMed ID: 20663135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
